Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 435Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 36VIIV HLTHCARE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

US Patent Number : 7125879

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 210192

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2025-04-21

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

US Patent Number : 10426780

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 210192

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2031-01-24

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM; LAMIVUDINE

US Patent Number : 11234985

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211994

Patent Use Code : U-257

Delist Requested :

Patent Use Description : TREATMENT OF HIV INFEC...

Patent Expiration Date : 2031-01-24

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM

US Patent Number : 8129385

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-05

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

US Patent Number : 9242986

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205551

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-08

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM

US Patent Number : 8129385

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-05

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDE

US Patent Number : 9242986

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 210192

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-08

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM

US Patent Number : 9242986

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204790

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-08

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

DOLUTEGRAVIR SODIUM

US Patent Number : 9242986

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213983

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-12-08

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE

US Patent Number : 8129385

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205551

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-05

blank